Emily Roarty

2.7k citations

24 papers · 480 indexed · h-index 10

Impact in

Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in ⓘ

Cancer Research 12
- Cancer Genomics and Diagnostics 12
Oncology 18
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 4
- Colorectal Cancer Treatments and Studies 3

Co-authors: John V. Heymach (24 shared papers)Stephen G. Swisher (12 shared papers)Jianjun Zhang (14 shared papers)J. Jack Lee (6 shared papers)Lara Lacerda (4 shared papers)William N. William (2 shared papers)Gustavo Schvartsman (2 shared papers)Marcelo F. Benveniste (2 shared papers)
Journals: Journal of Thoracic Oncology (9 papers)Journal of Clinical Oncology (7 papers)Clinical Lung Cancer (2 papers)Cancer Research (2 papers)Lung Cancer (1 paper)
Partner nations: United States Israel

In The Last Decade

Emily Roarty

23 papers receiving 478 citations

Peers

Countries citing papers authored by Emily Roarty

Since Specialization

Citations

This map shows the geographic impact of Emily Roarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Roarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Roarty more than expected).

Fields of papers citing papers by Emily Roarty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Roarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Roarty. The network helps show where Emily Roarty may publish in the future.

Co-authors

The 25 scholars most cited alongside Emily Roarty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emily Roarty Line = papers co-authored together Emily Roarty links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer Lung Cancer ·Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis, J. Jack Lee, Marcelo F. Benveniste, Jianjun Zhang, Emily Roarty, Lara Lacerda, Stephen G. Swisher, John V. Heymach, Frank V. Fossella, William N. William	2017	161
2	PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell Lung Cancer Journal of Thoracic Oncology ·Marcelo V. Negrão, Vincent K. Lam, Alexandre Reuben, Maria Laura Rubin, L.L. Landry, Emily Roarty, Waree Rinsurongkawong, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, Don L. Gibbons, Ignacio I. Wistuba, Vassiliki A. Papadimitrakopoulou, Bonnie S. Glisson, George R. Blumenschein, J. Jack Lee, John V. Heymach, Jianjun Zhang	2019	69
3	Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC Journal of Thoracic Oncology ·Vincent K. Lam, Jianjun Zhang, Carol C. Wu, Hai T. Tran, Lerong Li, Lixia Diao, Jing Wang, Waree Rinsurongkawong, Victoria M. Raymond, Richard B. Lanman, Jeff Lewis, Emily Roarty, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, Don L. Gibbons, Vassiliki A. Papadimitrakopoulou, John V. Heymach	2020	58
4	Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC) Clinical Lung Cancer ·Yasir Y. Elamin, Daniel R. Gomez, Mara B. Antonoff, Jacqulyne Robichaux, Hai T. Tran, Melissa K. Shorter, Jadi M. Bohac, Marcelo V. Negrão, Xiuning Le, Waree Rinsurogkawong, Jeff Lewis, Lara Lacerda, Emily Roarty, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, Vassiliki A. Papadimitrakopoulou, John V. Heymach	2018	44
5	Association of EGFR and HER-2 exon 20 mutations with distinct patterns of response to immune checkpoint blockade in non-small cell lung cancer. Journal of Clinical Oncology ·Marcelo V. Negrão, Alexandre Reuben, Jacqulyne Robichaux, Xiuning Le, Monique B. Nilsson, Chang‐Jiun Wu, Jianhua Zhang, L.C.A.D.L. Landry, Emily Roarty, Waree Rinsurongkawong, Stephen G. Swisher, George R. Simon, P. Andrew Futreal, Bonnie S. Glisson, Jianjun Zhang, John V. Heymach	2018	37
6	Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations Clinical Lung Cancer ·Vincent K. Lam, Hai T. Tran, Kimberly C. Banks, Richard B. Lanman, Waree Rinsurongkawong, Nir Peled, Jeff Lewis, J. Jack Lee, Jack A. Roth, Emily Roarty, Stephen G. Swisher, AmirAli Talasaz, P. Andrew Futreal, Vassiliki A. Papadimitrakopoulou, John V. Heymach, Jianjun Zhang	2018	32
7	DNA methylation intratumor heterogeneity in localized lung adenocarcinomas Oncotarget ·Kelly Quek, Jun Li, Marcos R. Estecio, Jiexin Zhang, Junya Fujimoto, Emily Roarty, Latasha Little, Chi‐Wan Chow, Xingzhi Song, Carmen Behrens, Taiping Chen, William N. William, Stephen G. Swisher, John V. Heymach, Ignacio I. Wistuba, Jianhua Zhang, P. Andrew Futreal, Jianjun Zhang	2017	23
8	Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations BMC Cancer ·Roberto Ruiz‐Cordero, Junsheng Ma, Abha Khanna, Genevieve Lyons, Waree Rinsurongkawong, Roland L. Bassett, Ming Guo, Mark J. Routbort, Jianjun Zhang, Ferdinandos Skoulidis, John V. Heymach, Emily Roarty, Zhenya Tang, L. Jeffrey Medeiros, Keyur P. Patel, Rajyalakshmi Luthra, Sinchita Roy‐Chowdhuri	2020	14
9	Spatial and temporal heterogeneity of PD-L1 and its impact on benefit from immune checkpoint blockade in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology ·Lingzhi Hong, Seyedeh Dibaj, Marcelo V. Negrão, Alexandre Reuben, Emily Roarty, Waree Rinsurongkawong, Jeff Lewis, Don L. Gibbons, Boris Sepesi, Vassiliki A. Papadimitrakopoulou, Bonnie S. Glisson, George R. Blumenschein, Phillip Andrew Futreal, Ignacio I. Wistuba, Jack A. Roth, Stephen G. Swisher, John V. Heymach, George R. Simon, J. Jack Lee, Jianjun Zhang	2019	10
10	Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer The Annals of Thoracic Surgery ·K. G. Mitchell, Marcelo V. Negrão, Edwin R. Parra, Jun Li, Jianhua Zhang, Hitoshi Dejima, Ara A. Vaporciyan, Stephen G. Swisher, Annikka Weissferdt, Mara B. Antonoff, Tina Cascone, Emily Roarty, Ignacio I. Wistuba, John V. Heymach, Don L. Gibbons, Jianjun Zhang, Boris Sepesi	2019	9
11	MA04.07 Impact of Major Co-Mutations on the Immune Contexture and Response of KRAS-Mutant Lung Adenocarcinoma to Immunotherapy Journal of Thoracic Oncology ·Ferdinandos Skoulidis, Yasir Y. Elamin, Vassiliki A. Papadimitrakopoulou, Pan Tong, Jing Wang, Jeff Lewis, Waree Rinsurongkawong, Caleb T. Chu, Emily Roarty, Jianjun Zhang, Hai T. Tran, Jaime Rodriguez‐Canales, Edwin R. Parra, Carmen Behrens, Humam Kadara, Ignacio I. Wistuba, John V. Heymach	2017	7
12	Landscape of EGFR-dependent and independent mechanisms of osimertinib resistance in EGFR-mutant NSCLC patients. Journal of Clinical Oncology ·Xiuning Le, Sonam Puri, Marcelo V. Negrão, Monique B. Nilsson, Jacqulyne Robichaux, Theresa A. Boyle, J. Kevin Hicks, Emily Roarty, Waree Rinsurongkawong, Bonnie S. Glisson, Jianjun Zhang, Vassiliki A. Papadimitrakopoulou, Jhanelle E. Gray, John V. Heymach	2018	3
13	P2.04-09 Driver Mutations are Associated with Distinct Patterns of Response to Immune Checkpoint Blockade in Non-Small Cell Lung Cancer Journal of Thoracic Oncology ·Marcelo V. Negrão, Alexandre Reuben, Jacqulyne Robichaux, Xiuning Le, Monique B. Nilsson, Yasir Y. Elamin, Chang‐Jiun Wu, J. Zhang, L.L. Landry, Emily Roarty, Waree Rinsurongkawong, Stephen G. Swisher, George R. Simon, P. Andrew Futreal, Bonnie S. Glisson, John V. Heymach	2018	2
14	Response to single-agent (SA) chemotherapy (CTx) after immunotherapy exposure in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology ·Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis, J. Jack Lee, Marcelo F. Benveniste, Jianjun Zhang, Waree Rinsurongkawong, Jeff Lewis, Emily Roarty, Lara Lacerda, Jack A. Roth, Stephen G. Swisher, John V. Heymach, Frank V. Fossella, William Nassib William	2017	2
15	P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients with Metastatic Non-Small Cell Lung Cancer Journal of Thoracic Oncology ·Loretta A. Williams, Shiva Dibaj, Sheenu Chandwani, Viralkumar Vaghani, Qiuling Shi, M. Hirschmann, L.L. Landry, Emily Roarty, J. Zhang, W. Rinsurnogkawong, Jeffery D. Lewis, Thomas Burke, Charles S. Cleeland, Jes Chauviere Lee, Jack A. Roth, S. Swisher, John V. Heymach, George R. Simon	2018	1
16	MA19.03 Differences in Symptom Burden Between Responsive and Progressive Disease in Advanced Non-Small Cell Lung Cancer (aNSCLC) Journal of Thoracic Oncology ·Loretta A. Williams, Qiuling Shi, Belqis El Ferjani, M. Hirschmann, Darcy Ponce, Seyedeh Dibaj, Sheenu Chandwani, Emily Roarty, Waree Rinsurongkawong, Jeff Lewis, Thomas Burke, Charles S. Cleeland, Jes Chauviere Lee, Jack A. Roth, S. Swisher, John V. Heymach, J. Zhang, George R. Simon	2019	1
17	MA14.03 The Impact of Genomic Landscape of EGFR Mutant NSCLC on Response to Targeted and Immune Therapy Journal of Thoracic Oncology ·Yasir Y. Elamin, Waree Rinsurongkawong, Hai T. Tran, Kathryn A. Gold, Jeff Lewis, Emily Roarty, P. Andrew Futreal, Jianjun Zhang, John V. Heymach	2017	1
18	P2.03a-048 The CDK4/6 Inhibitor G1T28 Protects Immune Cells from Cisplatin-Induced Toxicity in vivo and Inhibits SCLC Tumor Growth Journal of Thoracic Oncology ·Irene Guijarro, Alissa Poteete, Renata Ferrarotto, Warren L. Denning, Haïfa Hamdi, Patrick J. Roberts, Rajesh Malik, John Bisi, Jessica A. Sorrentino, Jay C. Strum, Emily Roarty, John V. Heymach	2017	1
19	P3.01-91 Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic Landscape Journal of Thoracic Oncology ·Viralkumar Vaghani, Sheenu Chandwani, M. Hirschmann, Seyedeh Dibaj, L.L. Landry, Emily Roarty, J. Zhang, W. Rinsurnogkawong, Jeff Lewis, Jes Chauviere Lee, Jack A. Roth, Stephen G. Swisher, John V. Heymach, Thomas Burke, George R. Simon	2018	1
20	Molecular biology and treatment strategies for non-V600 BRAF-mutant NSCLC. Journal of Clinical Oncology ·Marcelo V. Negrão, Victoria M. Raymond, Richard B. Lanman, Patrick Kwok Shing Ng, Rebecca J. Nagy, Kimberly C. Banks, Viola W. Zhu, Bianca Amador, Emily Roarty, Young Kwang Chae, Jeffrey Clarke, Jeffrey Crawford, Sai‐Hong Ignatius Ou, David R. Gandara, John V. Heymach, Trever G. Bivona, Caroline E. McCoach	2019	1

About Emily Roarty

Emily Roarty is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Biotechnology, having authored 24 papers that have together received 480 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Ferroptosis and cancer prognosis (4 papers), Lung Cancer Research Studies (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Gastric Cancer Management and Outcomes (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Oncology (348 citations), Pulmonary and Respiratory Medicine (330 citations), Cancer Research (138 citations), Otorhinolaryngology (19 citations) and Immunology (54 citations). Emily Roarty has collaborated with scholars based in United States and Israel. Frequent co-authors include John V. Heymach, Stephen G. Swisher, Jianjun Zhang, J. Jack Lee, Lara Lacerda, William N. William, Gustavo Schvartsman, Marcelo F. Benveniste, S. Andrew Peng and Frank V. Fossella. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Clinical Lung Cancer, Cancer Research and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact